This report is available for purchase for $199.

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deal activity, this review details the biopharma start-up dealmaking and financing from July through September 2016.


Biomedtracker is featuring content from sources within Informa's Pharma Intelligence to augment its original report content. This article was originally published by Scrip, October 2016. Scrip has experienced writers and analysts based in key geographic markets and cover all aspects of the industry – from small biotech start-ups to multinational giants, research boutiques to generic manufacturers. Scrip focuses on the whole of the drug discovery and development value chain and report on regulatory news, product approvals and rejections, and key corporate events.

For more information about Scrip, please visit Scrip here.

For more information about Strategic Transactions, please visit Strategic Transactions here.

For our disclosures, please read the Biomedtracker Research Standards.